Suchergebnisse - "Brufsky, Adam"

PubPharm (533)

91

MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice

enthalten in: JNCI cancer spectrum | 2021

von Paterson, A. | Lucas, P. | Anderson, S. | +14

92

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

enthalten in: Breast cancer research and treatment | 2021

von Moy, B. | Oliveira, M. | Saura, C. | +22

93

Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry

enthalten in: Breast cancer research and treatment | 2021

von Kaufman, P. | Hurvitz, S. | O'Shaughnessy, J. | +11

94

COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street?

enthalten in: Biomolecules | 2021

von Lundstrom, K. | Barh, D. | Uhal, B. | +23

95

Physical activity, cardiorespiratory fitness, and cognitive function in postmenopausal women with breast cancer

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2021

von Bender, C. | Sereika, S. | Gentry, A. | +11

96

Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2

enthalten in: International journal of biological macromolecules | 2021

von Hassan, S. | Attrish, D. | Ghosh, S. | +22

97

A unique view of SARS-CoV-2 through the lens of ORF8 protein

enthalten in: Computers in biology and medicine | 2021

von Hassan, S. | Aljabali, A. | Panda, P. | +29

98

Considerations of the effects of commonly investigated drugs for COVID-19 in the cholesterol synthesis pathway

enthalten in: Expert opinion on pharmacotherapy | 2021

von Gomez Marti, J. | Brufsky, A.

99

Carbon-Based Nanomaterials : Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era

enthalten in: ACS nano | 2021

von Serrano-Aroca, �. | Takayama, K. | Tuñón-Molina, A. | +20

100

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

enthalten in: Breast cancer research and treatment | 2021

von Moy, B. | Oliveira, M. | Saura, C. | +22